University of Pittsburgh: Psychotic Disorders trials
The registry lists 11 Psychotic Disorders studies with University of Pittsburgh as lead sponsor. 1 are open to participants now and 1 have results posted.
Phase 1 1Phase 2 3Phase 4 3No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Feasibility and Acceptability of Mobile Mental Health App for SZ and SZANot yet recruitingNCT06474325Not applicable
- Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid SupplementationCompletedNCT00167310Phase 2Results posted
- Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric DisordersCompletedNCT07043803Not applicable
- Neural Biomarkers of Clozapine ResponseCompletedNCT03076346
- Valacyclovir Augmentation for Cognitive and Functional Remediation in SchizophreniaCompletedNCT01794897Phase 4
- Adapted Cognitive/Affective Remediation for Cannabis Misuse in SchizophreniaCompletedNCT01292577Phase 1/2
- Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes MellitusCompletedNCT00222807
- A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With SchizophreniaCompletedNCT00222794Phase 4
- Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With PravastatinCompletedNCT00177580Phase 4
- L-carnosine for SchizophreniaCompletedNCT00177177Not applicable
- Treatment of Schizophrenia Through Internet-Based PsychoeducationCompletedNCT00051233Phase 2